A Three-Compartment Pharmacokinetic Model to Predict the Interstitial Concentration of Talaporfin Sodium in the Myocardium for Photodynamic Therapy: A Method Combining Measured Fluorescence and Analysis of the Compartmental Origin of the Fluorescence

To evaluate the effectiveness of photodynamic therapy occurring in the interstitial space of the myocardium, we estimated the interstitial concentration of talaporfin sodium in the canine myocardium by constructing a three-compartment pharmacokinetic model based on measured changes in talaporfin sod...

Full description

Bibliographic Details
Main Authors: Yuko Uno, Emiyu Ogawa, Eitaro Aiyoshi, Tsunenori Arai
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Bioengineering
Subjects:
Online Access:http://www.mdpi.com/2306-5354/6/1/1
id doaj-b7a2bb9fb1084c28851d82a84576e958
record_format Article
spelling doaj-b7a2bb9fb1084c28851d82a84576e9582020-11-25T01:04:20ZengMDPI AGBioengineering2306-53542018-12-0161110.3390/bioengineering6010001bioengineering6010001A Three-Compartment Pharmacokinetic Model to Predict the Interstitial Concentration of Talaporfin Sodium in the Myocardium for Photodynamic Therapy: A Method Combining Measured Fluorescence and Analysis of the Compartmental Origin of the FluorescenceYuko Uno0Emiyu Ogawa1Eitaro Aiyoshi2Tsunenori Arai3School of Fundamental Science and Technology, Graduate School of Science and Technology, Keio University, 3-14-1, Hiyoshi, Kohoku-ku, Yokohama City, Kanagawa 223-8522, JapanSchool of Allied Health Science, Kitasato University, Kanagawa 252-0373, JapanThe Institute of Statistical Mathematics, Tokyo 190-0014, JapanSchool of Fundamental Science and Technology, Graduate School of Science and Technology, Keio University, 3-14-1, Hiyoshi, Kohoku-ku, Yokohama City, Kanagawa 223-8522, JapanTo evaluate the effectiveness of photodynamic therapy occurring in the interstitial space of the myocardium, we estimated the interstitial concentration of talaporfin sodium in the canine myocardium by constructing a three-compartment pharmacokinetic model based on measured changes in talaporfin sodium plasma concentration and myocardial fluorescence. Differential rate equations of talaporfin sodium concentration in the plasma, interstitial space, and cell compartment were developed with individual compartment volume, concentration, and rate constants. Using measured volume ratios based on histological examinations, we defined that the myocardial fluorescence consisted of the linear addition of fluorescence generated from these three compartments. The rate constants were obtained by fitting to minimize the sum of the squared errors between the measured talaporfin sodium concentrations and the calculated concentrations divided by the number of data points using the conjugate gradient method in MATLAB. We confirmed that this fitting operation may be appropriate, because a coefficient of determination between the measured talaporfin sodium changes and the calculated concentrations using our equations was 0.99. Consequently, to estimate the interstitial concentration in the canine myocardium, we propose a three-compartment pharmacokinetic model construction methodology using measured changes in talaporfin sodium plasma concentration and changes in myocardial fluorescence.http://www.mdpi.com/2306-5354/6/1/1talaporfin sodiumpharmacokineticsthree-compartment modelinterstitial spacemyocardial fluorescence
collection DOAJ
language English
format Article
sources DOAJ
author Yuko Uno
Emiyu Ogawa
Eitaro Aiyoshi
Tsunenori Arai
spellingShingle Yuko Uno
Emiyu Ogawa
Eitaro Aiyoshi
Tsunenori Arai
A Three-Compartment Pharmacokinetic Model to Predict the Interstitial Concentration of Talaporfin Sodium in the Myocardium for Photodynamic Therapy: A Method Combining Measured Fluorescence and Analysis of the Compartmental Origin of the Fluorescence
Bioengineering
talaporfin sodium
pharmacokinetics
three-compartment model
interstitial space
myocardial fluorescence
author_facet Yuko Uno
Emiyu Ogawa
Eitaro Aiyoshi
Tsunenori Arai
author_sort Yuko Uno
title A Three-Compartment Pharmacokinetic Model to Predict the Interstitial Concentration of Talaporfin Sodium in the Myocardium for Photodynamic Therapy: A Method Combining Measured Fluorescence and Analysis of the Compartmental Origin of the Fluorescence
title_short A Three-Compartment Pharmacokinetic Model to Predict the Interstitial Concentration of Talaporfin Sodium in the Myocardium for Photodynamic Therapy: A Method Combining Measured Fluorescence and Analysis of the Compartmental Origin of the Fluorescence
title_full A Three-Compartment Pharmacokinetic Model to Predict the Interstitial Concentration of Talaporfin Sodium in the Myocardium for Photodynamic Therapy: A Method Combining Measured Fluorescence and Analysis of the Compartmental Origin of the Fluorescence
title_fullStr A Three-Compartment Pharmacokinetic Model to Predict the Interstitial Concentration of Talaporfin Sodium in the Myocardium for Photodynamic Therapy: A Method Combining Measured Fluorescence and Analysis of the Compartmental Origin of the Fluorescence
title_full_unstemmed A Three-Compartment Pharmacokinetic Model to Predict the Interstitial Concentration of Talaporfin Sodium in the Myocardium for Photodynamic Therapy: A Method Combining Measured Fluorescence and Analysis of the Compartmental Origin of the Fluorescence
title_sort three-compartment pharmacokinetic model to predict the interstitial concentration of talaporfin sodium in the myocardium for photodynamic therapy: a method combining measured fluorescence and analysis of the compartmental origin of the fluorescence
publisher MDPI AG
series Bioengineering
issn 2306-5354
publishDate 2018-12-01
description To evaluate the effectiveness of photodynamic therapy occurring in the interstitial space of the myocardium, we estimated the interstitial concentration of talaporfin sodium in the canine myocardium by constructing a three-compartment pharmacokinetic model based on measured changes in talaporfin sodium plasma concentration and myocardial fluorescence. Differential rate equations of talaporfin sodium concentration in the plasma, interstitial space, and cell compartment were developed with individual compartment volume, concentration, and rate constants. Using measured volume ratios based on histological examinations, we defined that the myocardial fluorescence consisted of the linear addition of fluorescence generated from these three compartments. The rate constants were obtained by fitting to minimize the sum of the squared errors between the measured talaporfin sodium concentrations and the calculated concentrations divided by the number of data points using the conjugate gradient method in MATLAB. We confirmed that this fitting operation may be appropriate, because a coefficient of determination between the measured talaporfin sodium changes and the calculated concentrations using our equations was 0.99. Consequently, to estimate the interstitial concentration in the canine myocardium, we propose a three-compartment pharmacokinetic model construction methodology using measured changes in talaporfin sodium plasma concentration and changes in myocardial fluorescence.
topic talaporfin sodium
pharmacokinetics
three-compartment model
interstitial space
myocardial fluorescence
url http://www.mdpi.com/2306-5354/6/1/1
work_keys_str_mv AT yukouno athreecompartmentpharmacokineticmodeltopredicttheinterstitialconcentrationoftalaporfinsodiuminthemyocardiumforphotodynamictherapyamethodcombiningmeasuredfluorescenceandanalysisofthecompartmentaloriginofthefluorescence
AT emiyuogawa athreecompartmentpharmacokineticmodeltopredicttheinterstitialconcentrationoftalaporfinsodiuminthemyocardiumforphotodynamictherapyamethodcombiningmeasuredfluorescenceandanalysisofthecompartmentaloriginofthefluorescence
AT eitaroaiyoshi athreecompartmentpharmacokineticmodeltopredicttheinterstitialconcentrationoftalaporfinsodiuminthemyocardiumforphotodynamictherapyamethodcombiningmeasuredfluorescenceandanalysisofthecompartmentaloriginofthefluorescence
AT tsunenoriarai athreecompartmentpharmacokineticmodeltopredicttheinterstitialconcentrationoftalaporfinsodiuminthemyocardiumforphotodynamictherapyamethodcombiningmeasuredfluorescenceandanalysisofthecompartmentaloriginofthefluorescence
AT yukouno threecompartmentpharmacokineticmodeltopredicttheinterstitialconcentrationoftalaporfinsodiuminthemyocardiumforphotodynamictherapyamethodcombiningmeasuredfluorescenceandanalysisofthecompartmentaloriginofthefluorescence
AT emiyuogawa threecompartmentpharmacokineticmodeltopredicttheinterstitialconcentrationoftalaporfinsodiuminthemyocardiumforphotodynamictherapyamethodcombiningmeasuredfluorescenceandanalysisofthecompartmentaloriginofthefluorescence
AT eitaroaiyoshi threecompartmentpharmacokineticmodeltopredicttheinterstitialconcentrationoftalaporfinsodiuminthemyocardiumforphotodynamictherapyamethodcombiningmeasuredfluorescenceandanalysisofthecompartmentaloriginofthefluorescence
AT tsunenoriarai threecompartmentpharmacokineticmodeltopredicttheinterstitialconcentrationoftalaporfinsodiuminthemyocardiumforphotodynamictherapyamethodcombiningmeasuredfluorescenceandanalysisofthecompartmentaloriginofthefluorescence
_version_ 1725198767526772736